Q&A

  • A photo shows Insulet Chief Medical Officer Trang Ly
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip
    Q&A

    Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

    Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.

    By • Aug. 27, 2024
  • A person playing a guitar in front of a microphone holds up a phone with a blood glucose reading on it.
    Image attribution tooltip
    Courtesy of Ascensia Diabetes Care
    Image attribution tooltip
    Q&A

    Ascensia’s new head of CGM talks plans for a 365-day sensor

    Brian Hansen recently joined Ascensia, which markets Senseonics’ implantable glucose sensors. The current version lasts 180 days, but Senseonics is seeking FDA approval for a one-year sensor.

    By • Aug. 6, 2024
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip
    Q&A

    Tandem CMO shares Mobi feedback, expansion plans

    MedTech Dive caught up with Chief Medical Officer Jordan Pinsker to talk about early feedback on Tandem’s smallest insulin pump and what’s next for the device.

    By • July 29, 2024
  • Medtronic's Stacey Churchwell is pictured wearing a blue suit jacket and white shirt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Q&A

    ‘Our next frontier is prediction’: Medtronic on AI and heart disease

    Stacey Churchwell, who leads the company’s cardiovascular diagnostics and services business, says artificial intelligence is reducing false positives in its insertable cardiac monitors, saving clinicians valuable time.

    By • July 22, 2024
  • A blue, wavy device resembles a thin sponge.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip
    Q&A

    J&J’s Nisha Johnson on Ethizia wound-sealing patch, biosurgery market

    With the recent launch of the hemostatic healing patch in Europe, J&J expects to lead the biosurgery and wound closure market. 

    By • May 28, 2024
  • A headshot of Jennifer Jones-McMeans, who is smiling in the photo. She is wearing an orange blouse and blue hoop earrings.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s Jennifer Jones-McMeans on treating PAD below the knee

    Jennifer Jones-McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

    By • May 9, 2024
  • A headshot of Dr. Nadim Geloo
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s Nadim Geloo on Triclip’s US launch, Edwards competition

    The senior medical director for structural heart discussed the Triclip rollout, Edwards’ rival tricuspid treatment and Abbott’s aortic valve clinical trial.

    By • April 12, 2024
  • Professional photo of Aldo Denti
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip
    Q&A

    J&J’s Aldo Denti on digital technology in orthopedics

    The chairman of J&J subsidiary DePuy Synthes talked about how surgical robots and other technologies have contributed to procedures moving to outpatient facilities.

    By • Updated April 1, 2024
  • Professional photo of Katherine Truppi
    Image attribution tooltip
    Permission granted by Stryker
    Image attribution tooltip
    Q&A

    Stryker’s next head of joint replacement talks about new revision, robotics products

    Katherine Truppi will become president of Stryker’s joint replacement business on March 31 after more than 20 years at the company.

    By • March 22, 2024
  • An image of Abbott's electrophysiology chief medical officer Christopher Piorkowski, who is smiling and wearing a suit and tie.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation

    Christopher Piorkowski, chief medical officer for the electrophysiology business, talks about the high expectations for the new atrial fibrillation treatment.

    By • March 1, 2024
  • A headshot of Per Langoe, new CEO of GT Medical, wearing a suit jacket.
    Image attribution tooltip
    Permission granted by GT Medical Technologies
    Image attribution tooltip
    Q&A

    New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy

    Langoe, the former head of Palette Life Sciences, spoke about his plans to expand use of GT Medical’s cancer-fighting implant.

    By • Feb. 23, 2024
  • Portrait of Bill Hunter
    Image attribution tooltip
    Permission granted by Canary Medical
    Image attribution tooltip
    Q&A

    Canary CEO Bill Hunter talks smart knee implant progress, new heart device

    The company collaborated with Zimmer Biomet on its Persona IQ device, which is slated for a full market release this year. Canary is also working on an implantable monitor for heart failure patients.

    By • Feb. 15, 2024
  • A head shot of Grail CEO Bob Ragusa
    Image attribution tooltip
    Permission granted by Grail
    Image attribution tooltip

    Grail CEO predicts ‘transformative’ 2024 amid Illumina split

    The liquid biopsy maker, which Illumina plans to divest, said it has made progress on a PMA application with the FDA for its Galleri multi-cancer early detection test.

    By • Dec. 19, 2023
  • A photo of Anne Osdoit, CEO of Moon Surgical.
    Image attribution tooltip
    Permission granted by Moon Surgical
    Image attribution tooltip
    Q&A

    Moon Surgical CEO Anne Osdoit on readying a soft tissue robot for launch

    With support from J&J’s venture capital arm and chip maker Nvidia, Moon is targeting a soft tissue surgery market dominated by Intuitive Surgical.

    By • Dec. 1, 2023
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip
    Q&A

    Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s

    The CEO said the company’s growth expectations have not changed in the near term, even with the rise of weight loss drugs.

    By • Nov. 21, 2023
  • A metal device with a curved piece on top of a plate
    Image attribution tooltip
    Courtesy of Stryker
    Image attribution tooltip
    Q&A

    Stryker’s Lisa Kloes talks cementless implants, robotics as future of knee business

    The manager of Stryker’s knee business also discussed the growing role of ambulatory surgery centers in orthopedics.

    By • Updated Nov. 8, 2023
  • Baxter's Heather Knight is pictured with a lamp and sofa in the background.
    Image attribution tooltip
    Permission granted by Baxter International
    Image attribution tooltip
    Q&A

    Baxter’s Heather Knight talks combating sepsis — and how AI can help

    The company’s group president for medical products and therapies says the right fluid management practices can help save lives and lower hospital costs.

    By • Oct. 27, 2023
  • Professional photo of Jan Makela
    Image attribution tooltip
    Permission granted by GE HealthCare
    Image attribution tooltip
    Q&A

    GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

    GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.

    By • Oct. 6, 2023
  • Professional photo of Jeffrey Brewer
    Image attribution tooltip
    Permission granted by Bigfoot Biomedical
    Image attribution tooltip
    Q&A

    Bigfoot CEO talks Abbott acquisition, future of diabetes tech

    Jeffrey Brewer hopes to see more integrated solutions for people with diabetes, starting with the company’s partnership with Abbott.

    By • Sept. 15, 2023
  • Intuitive Surgical's Tony Jarc is wearing a dark blue jacket and white shirt in a corporate head shot.
    Image attribution tooltip
    Permission granted by Intuitive Surgical
    Image attribution tooltip
    Q&A

    Intuitive’s Tony Jarc on how AI is improving robotic surgery

    The company aims to help surgeons achieve better results for patients and hospitals.

    By • Sept. 8, 2023
  • Professional photo of Rebecca Whitney
    Image attribution tooltip
    Permission granted by ZimVie
    Image attribution tooltip
    Q&A

    ZimVie’s Rebecca Whitney sizes up the competition in cervical disc implants

    The company is bringing new products to market as it faces more challengers in cervical disc replacement and tethering for scoliosis.

    By • Sept. 1, 2023
  • Caroline Pearson, executive director of the Peterson Center on Healthcare
    Image attribution tooltip
    Permission granted by Peterson Center on Healthcare
    Image attribution tooltip
    Q&A

    Q&A: ‘Chaotic’ digital health market needs independent evaluation, new institute says

    Independent evaluation could help the healthcare industry figure out which digital health products are backed by evidence, argues Caroline Pearson, executive director of the nonprofit Peterson Center on Healthcare.

    By Emily Olsen • Aug. 11, 2023
  • A photo of Ben Sexson
    Image attribution tooltip
    Permission granted by Monogram Orthopedics
    Image attribution tooltip

    Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery

    The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.

    By • Aug. 4, 2023
  • Professional photo of Adam Elsesser
    Image attribution tooltip
    Permission granted by Penumbra
    Image attribution tooltip
    Q&A

    Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment

    Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs.

    By • July 7, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip
    Q&A

    Q&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users

    The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.

    By • June 30, 2023